Fiera Capital (Canada)’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,037,248
Closed -$28.6M 468
2024
Q4
$28.6M Sell
3,037,248
-175,313
-5% -$1.82M 0.09% 133
2024
Q3
$34.3M Sell
3,212,561
-2,067,881
-39% -$22.5M 0.1% 124
2024
Q2
$52.4M Buy
5,280,442
+58,113
+1% +$597K 0.16% 92
2024
Q1
$61.5M Buy
5,222,329
+160,685
+3% +$2.05M 0.18% 80
2023
Q4
$71.8M Sell
5,061,644
-24,227
-0.5% -$275K 0.22% 64
2023
Q3
$61.8M Buy
5,085,871
+106,086
+2% +$1.37M 0.2% 62
2023
Q2
$62.5M Sell
4,979,785
-121,579
-2% -$1.44M 0.18% 62
2023
Q1
$56.6M Sell
5,101,364
-87,793
-2% -$1.08M 0.17% 66
2022
Q4
$63.4M Buy
5,189,157
+1,172,602
+29% +$13.2M 0.2% 62
2022
Q3
$38.1M Sell
4,016,555
-66,317
-2% -$739K 0.14% 84
2022
Q2
$43.9M Sell
4,082,872
-73,876
-2% -$608K 0.13% 81
2022
Q1
$39.4M Buy
4,156,748
+155,907
+4% +$1.46M 0.1% 111
2021
Q4
$46.2M Buy
4,000,841
+936,234
+31% +$10.4M 0.11% 106
2021
Q3
$29.3M Sell
3,064,607
-54,313
-2% -$556K 0.08% 135
2021
Q2
$30.1M Sell
3,118,920
-87,570
-3% -$855K 0.08% 137
2021
Q1
$31.7M Buy
+3,206,490
New +$49.6M 0.09% 130

Other funds holding FOLD

Fiera Capital (Canada)'s FOLD Position: Q1 2025 in Review

Fiera Capital (Canada) sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 3,037,248 shares — an estimated $28.6M sold.

Fiera Capital (Canada) first reported a position in FOLD in Q1 2021 and held it in 16 quarters. The position peaked at $71.8M in Q4 2023. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.

  • Fiera Capital (Canada) reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Fiera Capital (Canada) sold 3,037,248 Amicus Therapeutics shares in Q1 2025, an estimated $28.6M.
  • Fiera Capital (Canada) first reported a position in Amicus Therapeutics in Q1 2021 and held it in 16 quarters.
  • Fiera Capital (Canada)'s Amicus Therapeutics position peaked at $71.8M in Q4 2023.
  • 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2025, filed 7 May 2025.